Skip to content

Venture Capital Platform
For Institutional Investors

Connect with VCs, LPs and Startups.

Syndicate and Co-Invest privately through trusted introductions - without intermediaries.

100+ VCs and LPs. 20+ Countries.

Venture Capital Made Efficient
Venture Capital Investors
Alpha VC
Beta Capital
Gamma Partners
Reach via your LP contact
Limited Partners
Pension Fund A
Endowment B
Family Office C

Syndication
Co-Investment
Follow-ons
Direct connections. No intermediaries. No SPVs.
Venture-Scale Startups
Venture Capital Investors
Alpha VC
Beta Capital
Gamma Partners
Reach via your VC contact
Venture-Scale Startups
Startup-1
Startup-2
Startup-3

Fundraising
Syndication
Follow-on rounds
Direct connections. No intermediaries. No SPVs.
Ireland’s life sciences and digital health startups posted their strongest year in a decade, drawing €491.3 million across 89 venture rounds in 2024, per PitchBook-powered analysis. Growth-stage and later financings expanded to 46% of activity- more than twice 2014’s share- underscoring a system shifting from seed-heavy to scale-oriented.Enterprise Ireland emerged as the year’s most active investor globally in the sector, joining 60 transactions and accelerating deployment from the €500 million Disruptive Technologies Innovation Fund. Of that, €454 million has been allocated to date, including €298 million to 68 health and wellbeing projects.Momentum carried into 2025 with a €115 million late-stage raise for Dublin medtech FIRE1, among Europe’s largest health tech rounds this year. FIRE1’s Norm platform embeds a sensor in the IVC to track fluid status in heart failure, pairs with a daily wearable belt, and streams readings to clinicians via cloud and app—aimed at reducing hospital reliance and improving patient decision-making.Ireland now ranks second in Europe for MedTech exports behind Switzerland, with €16 billion in annual shipments representing 14% of national exports. The country hosts more than 700 sector companies, including over 400 domestic ventures and nine of the top 10 multinational MedTech players.On the public side, digital patient access advanced: since September 2025, users at 31 hospitals can view appointments and health information through the HSE Health App, with rollouts continuing across the remaining hospitals.
6 days ago|by Team S
KKR & Co. delivered another standout quarter, underscoring its strength across asset management and insurance. The firm raised $43bn in new capital, set a record for fee-related earnings at $1bn, and continued to scale its platform with double-digit growth across strategies.Adjusted net income reached $1.3bn in the third quarter of 2025, up 8% year-on-year, while total operating earnings climbed 12% to $1.4bn. Assets under management (AUM) rose 16% YoY to $723bn, with fee-paying AUM at $585bn. KKR’s dry powder stood at $126bn, providing ample capacity to execute on new opportunities.Deployment remained brisk. The firm invested $26bn during the quarter - its most active period on record - and $85bn over the past twelve months, reflecting strong conviction across private equity, credit, infrastructure, and asset-based strategies.Insurance continues to be a growth engine. Global Atlantic contributed $305m in operating earnings and expanded its AUM to $212bn. The segment was further bolstered by a $2bn strategic investment from Japan Post Insurance, enhancing KKR’s footprint in retirement and reinsurance markets.KKR also advanced its sector reach with recent acquisitions. The purchase of HealthCare Royalty Partners added roughly $3bn to AUM and broadened exposure to biopharma royalty streams, complementing existing healthcare investments and income-oriented strategies.Across segments, momentum remained broad-based: private equity AUM climbed 17% YoY to $222bn, supported by fundraising for North America Fund XIV and K-Series vehicles; real assets rose 14% to $186bn; and credit and liquid strategies expanded 16% to $315bn, driven by CLO issuance and inflows to asset-based finance.The Strategic Holdings segment, focused on long-duration equity investments, delivered $58m in operating earnings and is projected to exceed $1bn annually by 2030, signaling a growing contribution from permanent capital-style positions.KKR declared a quarterly dividend of $0.185 per share, maintaining consistent returns to shareholders as the firm scales fee-based revenues and diversifies its earnings mix.
6 days ago|by Team S
The British Business Bank (BBB) is increasing co-investments directly into U.K. scaleups, aiming to plug funding gaps-especially between Seed and Series A and at growth stage-while crowding in private capital.Under the Modern Industrial Strategy, the BBB has been allocated £4 billion for priority sectors and £2.6 billion for broader startups. Since shifting its approach in 2021, it has passed £250 million in direct co-investments across 33 tech and life sciences companies, with plans for a higher share-potentially up to 25% of Industrial Strategy capital-done via co-investment.Selection follows two lenses: topping up existing fund-backed breakout companies guided by power law dynamics, and backing research-intensive deep-tech and life sciences (including many university spinouts) that need time and capital to reach market. The BBB is expanding its team and launching the British Growth Partnership to invest directly in growth-stage companies on behalf of institutional investors (e.g., NatWest Cushion, Aegon, London CIV), helping pension funds-per the Mansion House direction-engage with VC via curated products. Supporting policy includes pooling local government pensions by 2026, with at least one £100 billion pool, as outlined by Pensions Minister Torsten Bell, to enable larger schemes to bear VC risk and increase investment in innovation. Overall, the strategy uses public funds to crowd in private capital, easing access to growth funding for U.K. scaleups.
a month ago|by Team S
Designed for Institutional Investing

Verified Access

Every investor on Newnex is verified to ensure authenticity and trust. The network is exclusive to institutional participants across venture capital, LPs, and startups.

Networked Collaboration

VCs, LPs and Startups connect directly and privately with their peers. Cross-network connections are enabled through trusted introductions - ensuring quality, relevance and trust.

Private Investing, Without Intermediaries

Members can create fundraising and share within or outside Newnex. Investors receive deals - privately invited from other investors.

Connecting Capital
Without Intermediaries

Newnex draws on institutional investing experience across global pension funds and development finance institutions (DFIs).

Despite advances in private markets, institutional investing remains largely offline and constrained by LP restrictions that limit participation through intermediaries or SPVs. Existing digital platforms offer limited direct access and operate with centralized control, making them unsuitable for institutional use.

Newnex eliminates these frictions by enabling verified institutional investors to connect, syndicate, co-invest, raise, and deploy capital directly - without intermediaries or SPVs. The platform maintains investor autonomy and governance standards while enhancing efficiency, transparency, and execution across private markets.

Verified NetworkDirect AccessPrivate Deal Making
News and Views

Get the news and share the views.